RAD51 and hepatocellular carcinoma: While combining BNCT with sensitizing agents enhanced cytotoxicity in HCC cells, its impact on normal liver tissue remains uncertain, particularly given the non-selective distribution of boric acid and the systemic action of RAD51 inhibitors.